Organisation paid for research Program year 2025 Source: CMS Open Payments

A and A Research Group, Inc

Neither a doctor nor a teaching hospital

Research payments

$155,354

4 payments

Through program year 2025, A and A Research Group, Inc is reported as receiving $155,354 in research payments, across 4 payments.

By program year

1 row

Year	Kind	Amount	Payments
2025	Research	$155,354	4

Breakdown

Who paid Research payments · program year 2025

Novartis Pharmaceuticals Corporation $155,354 4 payments

Studies the money was for Research payments · program year 2025

A randomized double-blind, placebo-controlled, multicenter study to evaluate the efficacy, safety and tolerability of pelacarsen (TQJ230) in US Black/African American & Hispanic patient populations with elevated Lp(a) and established atherosclerotic cardi $88,286 1 payment
A Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Effect of Inclisiran on Preventing Major Adverse Cardiovascular Events in High-risk Primary Prevention Patients (VICTORION-1 PREVENT) $40,987 1 payment
Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial, Assessing the Impact of Inclisiran on Major Adverse Cardiovascular Events in Participants With Established Cardiovascular Disease (Victorion-2 Prevent) $17,127 1 payment
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open-Label Pelacarsen in Participants With Elevated Lp(a) and Established ASCVD $8,954 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.